PTC Therapeutics

-$0.17 (-0.52%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology.

CEO
Stuart Walter Peltz
Employees
1,177
Headquarters
South Plainfield, New Jersey
Founded
1998

PTCT Key Statistics

Market cap
2.31B
Price-Earnings ratio
—
Dividend yield
—
Average volume
651.12K
High today
$33.47
Low today
$31.44
Open price
$32.87
Volume
727.30K
52 Week high
$45.80
52 Week low
$30.03

PTCT News

Benzinga8h

Europe's CHMP Backs Approval Of PTC Therapeutics' Gene Therapy In Rare Neurometabolic Disorder

by The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of PTC Therapeutics Inc's PTCT Upsta

PTCT Earnings

-$2.03
-$1.35
-$0.68
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure